drugset / Trial / NCT00092586

Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

NCT00092586

Phase 3 Completed 2904 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this 6-week study is to compare the reduction in specific levels of cholesterol in patients with high cholesterol.

Timeline

Start
2002-09
Primary completion
2003-10
Completion
2003-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg

Indications